수의학 참조 실험실 시장 규모, 점유율, 동향 및 예측 : 기술별, 용도별, 대상 동물별, 지역별(2026-2034년)

The global veterinary reference laboratory market size was valued at USD 5.02 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 12.03 Billion by 2034, exhibiting a CAGR of 9.33% from 2026-2034. North America currently dominates the market, holding a market share of 42% in 2025. The region benefits from a well-established veterinary healthcare infrastructure, high companion animal ownership rates, and strong adoption of advanced diagnostic technologies across both companion and livestock animal care, all contributing to the veterinary reference laboratory market share.

The global veterinary reference laboratory market is driven by the rising prevalence of zoonotic and infectious diseases across livestock and companion animal populations, demanding robust diagnostic capabilities. Growing awareness among animal owners, farmers, and regulatory bodies about the value of early disease detection is increasing laboratory testing utilization. Expanding global trade in animal-derived food products is intensifying food safety testing requirements. Widespread adoption of molecular diagnostics, automation, and digital reporting platforms is transforming service delivery and broadening test menus. The convergence of human and animal health under the One Health framework is directing meaningful policy support and investment toward veterinary diagnostics worldwide.

The United States has emerged as a major region in the veterinary reference laboratory market owing to many factors. The country maintains one of the largest companion animal populations globally, sustaining strong demand for comprehensive veterinary diagnostic services. A mature regulatory environment governed by the USDA and FDA, alongside advanced veterinary education institutions and research infrastructure, supports a sophisticated laboratory testing ecosystem. In May 2025, Zoetis announced the opening of its newest and largest diagnostics reference laboratory at the UPS Healthcare Labport facility in Louisville, Kentucky, expanding national testing capacity and enabling faster, more precise diagnostic results for veterinary clinics across the United States. The growing integration of electronic health records and laboratory information management systems is streamlining diagnostic workflows and improving clinical accuracy. Increasing adoption of pet health insurance is further expanding diagnostic utilization among pet owners, reinforcing the country's veterinary reference laboratory market outlook.

Rising Pet Humanization and Companion Animal Care

The increasing humanization of pets is reshaping veterinary diagnostic demand significantly. As pet owners treat animals as family members, expectations for diagnostic thoroughness have risen substantially. This behavioral shift is generating stronger demand for comprehensive health screening panels, advanced pathology assessments, and specialized diagnostic services that only reference laboratories can provide. Veterinarians are increasingly relying on external reference laboratories for complex biochemistry, endocrinology, and genetic testing beyond in-house diagnostic capabilities. The growing prevalence of chronic conditions such as diabetes, kidney disease, and oncological disorders is increasing laboratory submission frequency. Senior pet care programs and preventive wellness protocols are further driving higher testing volumes across companion animal species.

Technological Advancements in Diagnostic Platforms

Rapid technological advancements are fundamentally transforming veterinary reference laboratory capabilities, enabling faster, more accurate, and cost-effective diagnostic outcomes. The adoption of next-generation sequencing, polymerase chain reaction technologies, and mass spectrometry is broadening available tests and facilitating more precise disease identification. The World Organisation for Animal Health (WOAH) supports global reference laboratory networks that enhance collaboration, standardize diagnostic methods, share expertise, and advance diagnostic capabilities for major animal diseases, strengthening laboratory infrastructure and disease surveillance worldwide. Automated laboratory systems and artificial intelligence-powered diagnostic tools are improving throughput and reducing human error, while cloud-based information management systems enable seamless data sharing between clinicians and laboratories. Digital pathology platforms allowing remote slide review by specialist pathologists are extending service reach across dispersed veterinary markets. These veterinary reference laboratory market trends are positioning advanced diagnostics as a cornerstone of precision veterinary medicine globally.

Growing Emphasis on Food Safety and Livestock Health

The intensification of global food safety regulations and rising consumer demand for pathogen-free animal-derived products are creating substantial growth opportunities for veterinary reference laboratories in the livestock sector. Regulatory authorities across major agricultural nations are mandating pathogen screening, antibiotic residue testing, and disease surveillance in livestock populations, driving increased testing volumes. For example, in January 2025, the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) updated its surveillance policy to enhance testing of turkey flocks for highly pathogenic avian influenza (HPAI), strengthening pathogen monitoring and laboratory diagnostic activities as part of national efforts to protect livestock health and food safety. Outbreaks of diseases such as avian influenza, foot-and-mouth disease, and African swine fever have reinforced the importance of early detection, directing government investment toward veterinary diagnostic infrastructure. The expansion of precision livestock farming practices is generating additional laboratory testing demand. The veterinary reference laboratory market forecast remains optimistic as regulatory frameworks and agricultural trade volumes continue expanding.

Analysis by Technology:

• Clinical Chemistry
• Hematology
• Immunodiagnostics
  • ELISA
  • Lateral Flow Rapid Tests
  • Others
• Molecular Diagnostics
  • PCR
  • Microassays
  • Others

Clinical chemistry holds 33% of the market share. Clinical chemistry encompasses a wide range of biochemical assays that evaluate the functional status of major organ systems, including the liver, kidneys, pancreas, and thyroid gland, making it an indispensable component of veterinary diagnostic evaluation. These tests analyze blood and urine samples to detect abnormalities in metabolic processes, electrolyte balance, and enzyme activity, providing veterinarians with essential data for diagnosing systemic diseases, monitoring treatment efficacy, and assessing pre-surgical risk profiles. The broad applicability of clinical chemistry panels across all animal species, from companion animals such as dogs and cats to livestock and exotic animals, underpins its dominant position within the veterinary reference laboratory testing portfolio. Advances in automated analyzers and multi-analyte panels are enabling faster result turnaround times and improved test precision, supporting more informed clinical decision-making.

Analysis by Application :

• Clinical Pathology
• Toxicology
• Productivity Testing

Clinical pathology leads the market with a share of 38%. Clinical pathology forms the diagnostic foundation of veterinary reference laboratory services, encompassing a comprehensive range of examinations including complete blood counts, serum biochemistry profiles, urinalysis, cytology, and coagulation studies. These evaluations enable veterinarians to systematically assess the health status of animals, identify pathological conditions affecting organ function, and guide treatment decisions across a broad spectrum of diseases. The comprehensive nature of clinical pathology testing makes it applicable to virtually every clinical presentation encountered in veterinary practice, from routine wellness assessments to complex critical care evaluations. The segment's prominence is further supported by the increasing adoption of electronic veterinary records, which facilitate seamless submission of laboratory requests and rapid reporting of results.

Analysis by Animal Type :

• Livestock Animals
• Companion Animals

Companion animals dominates the market, with a share of 63%. The companion animal segment occupies the dominant position in the veterinary reference laboratory market, driven by the dramatic increase in global pet ownership and the corresponding elevation in veterinary care standards for dogs, cats, and other household animals. The humanization of pets has translated into greater willingness among pet owners to invest in advanced diagnostics, including genetic testing, allergy profiling, infectious disease panels, and comprehensive wellness screenings. Companion animals frequently present with complex, multi-system conditions that require specialized laboratory evaluation beyond the capabilities of in-clinic analyzers, creating sustained demand for reference laboratory services. The proliferation of specialty and emergency veterinary hospitals in urban centers has further expanded diagnostic testing volumes for companion animals.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America, accounting for 42% of the share, enjoys the leading position in the market. North America's leadership in the global veterinary reference laboratory market is underpinned by a confluence of structural advantages, including the world's highest concentration of companion animal ownership, an extensive network of veterinary healthcare facilities, and robust regulatory and accreditation frameworks governing laboratory standards. The region benefits from a mature veterinary services infrastructure, with highly specialized veterinary hospitals, academic institutions, and research centers that generate consistent demand for complex diagnostic testing. The widespread adoption of preventive care protocols and wellness screening programs among North American pet owners creates a steady pipeline of laboratory submissions throughout the year. The region's regulatory bodies, including the USDA and FDA, actively enforce food safety and livestock disease surveillance requirements, generating substantial laboratory testing demand in the agricultural sector as well.

UNITED STATES VETERINARY REFERENCE LABORATORY MARKET ANALYSIS

The United States holds a strong position in North America as the most developed veterinary diagnostics market in the world, supported by decades of investment in veterinary education, research, and healthcare infrastructure. The country's large and diverse companion animal population, combined with a culturally embedded commitment to companion animal wellbeing, sustains exceptional demand for reference laboratory testing across a broad range of diagnostic categories. The US veterinary diagnostics sector benefits from close collaboration between academic veterinary hospitals, private diagnostic laboratories, and regulatory agencies, ensuring high standards of accuracy, accreditation, and quality assurance across all testing platforms. Government-mandated surveillance programs for zoonotic diseases, antimicrobial resistance monitoring, and food safety testing further generate substantial and reliable demand for veterinary reference laboratory services beyond the companion animal sector. The adoption of precision diagnostics, including genomic medicine and biomarker profiling, is accelerating rapidly within the United States as veterinary specialists seek more personalized approaches to disease management. The growing integration of telemedicine and digital pathology platforms is also expanding access to specialist laboratory expertise across geographically distributed veterinary practices nationwide, reinforcing the country's position as a global benchmark for veterinary diagnostic excellence.

EUROPE VETERINARY REFERENCE LABORATORY MARKET ANALYSIS

Europe represents a significant and mature market for veterinary reference laboratory services, characterized by a high density of companion animals, stringent regulatory standards, and well-developed veterinary healthcare infrastructure across its major economies. Countries such as Germany, France, the United Kingdom, and the Netherlands are among the most advanced markets for veterinary diagnostics in the region, supported by strong academic veterinary institutions and active professional associations promoting diagnostic best practices. In September 2026, Zoetis expanded the availability of its advanced Vetscan OptiCell AI powered veterinary hematology analyzer into Europe, enhancing point of care diagnostic capabilities and reinforcing the integration between in clinic testing and reference laboratory services across the region. The European Union's comprehensive animal health legislation, including mandatory disease notification and food safety testing requirements, creates consistent regulatory-driven demand for laboratory services across member states. The growing trend toward preventive veterinary care, wellness monitoring, and the adoption of specialist veterinary services is driving higher diagnostic testing volumes for companion animals throughout Western and Northern Europe. Emerging markets in Eastern Europe are also experiencing growth in veterinary services utilization, supported by rising living standards, expanding middle-class pet ownership, and improving access to veterinary care infrastructure, broadening the European market's overall scope and depth.

ASIA PACIFIC VETERINARY REFERENCE LABORATORY MARKET ANALYSIS

Asia-Pacific represents a high-growth region for veterinary reference laboratory services, driven by rapid urbanization, rising disposable incomes, and expanding companion animal ownership in key markets such as China, Japan, South Korea, Australia, and India. The region's large livestock sector, encompassing poultry, swine, and aquaculture, generates substantial demand for disease surveillance, productivity testing, and food safety laboratory services. Government initiatives aimed at strengthening national veterinary health systems and biosurveillance capabilities are directing investment toward diagnostic infrastructure. Japan and Australia maintain highly developed veterinary services markets with sophisticated reference laboratory networks, while China and India are rapidly building capacity to support their growing veterinary healthcare sectors. The increasing penetration of corporate veterinary chains and specialty pet hospitals across major urban centers is elevating diagnostic testing standards and driving higher reference laboratory utilization throughout the region.

LATIN AMERICA VETERINARY REFERENCE LABORATORY MARKET ANALYSIS

Latin America presents growing opportunities for veterinary reference laboratory services, underpinned by the region's large agricultural sector and increasing companion animal ownership in urban centers. Brazil and Mexico represent the most developed veterinary services markets in the region, with expanding networks of veterinary hospitals, clinics, and diagnostic laboratories serving both companion and livestock animal populations. Government-mandated food safety programs and disease surveillance requirements for major export commodities, including beef, poultry, and pork, are generating regulatory-driven demand for reference laboratory testing. Rising disposable incomes and increasing urbanization are also supporting broader adoption of companion animal care practices, incrementally expanding the addressable market for veterinary diagnostics services across Latin American markets.

MIDDLE EAST AND AFRICA VETERINARY REFERENCE LABORATORY MARKET ANALYSIS

The Middle East and Africa region represents an emerging market for veterinary reference laboratory services, with growth supported by expanding livestock sectors in Gulf Cooperation Council countries and sub-Saharan Africa, alongside growing companion animal ownership in urban centers. Government investments in food safety infrastructure, national disease surveillance programs, and veterinary public health initiatives are creating foundational demand for reference laboratory capabilities. The region's large camel, sheep, goat, and poultry populations generate specific testing requirements related to productivity, disease monitoring, and export certification. While laboratory infrastructure remains developing relative to mature markets, government-backed capacity building programs are progressively expanding access to advanced veterinary reference laboratory services across the region.

Competitive Landscape:

The global veterinary reference laboratory market is characterized by a moderately consolidated competitive landscape, with a mix of large multinational diagnostic companies, specialized independent laboratories, and academic or government-affiliated institutions competing across various testing segments and geographic markets. Leading market participants are actively investing in expanding their test menus, upgrading laboratory automation infrastructure, and developing proprietary diagnostic platforms to differentiate their service offerings and improve operational efficiency. Strategic acquisitions, laboratory network expansions, and partnerships with veterinary practice chains represent key competitive strategies employed by major players seeking to broaden geographic reach and customer base. The adoption of digital reporting systems, telemedicine-integrated diagnostics, and artificial intelligence-assisted result interpretation is emerging as a new axis of competitive differentiation. Increasing regulatory requirements for laboratory accreditation and quality standards are raising the barrier to entry, favoring established players with robust quality management systems and extensive diagnostic expertise across multiple animal species and testing disciplines.

The report provides a comprehensive analysis of the competitive landscape in the veterinary reference laboratory market with detailed profiles of all major companies, including:

• Boehringer Ingelheim GmbH
• IDEXX Laboratories Inc.
• Neogen Corporation
• Phoenix Central Laboratory for Veterinarians Inc. (Zoetis Inc.)
• ProtaTek International Inc. (Pharmgate LLC)
• Royal GD
• Texas A&M Veterinary Medical Diagnostic Laboratory
• VCA Inc. (Mars Incorporated)
• Virbac Animal Health India Private Limited

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the veterinary reference laboratory market?

2. What is the future outlook of the veterinary reference laboratory market?

3. What are the key factors driving the veterinary reference laboratory market?

4. Which region accounts for the largest veterinary reference laboratory market share?

5. Which are the leading companies in the global veterinary reference laboratory market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Reference Laboratory Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Clinical Chemistry
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Hematology
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Immunodiagnostics
  • 6.3.1 Market Trends
  • 6.3.2 Major Types
    • 6.3.2.1 ELISA
    • 6.3.2.2 Lateral Flow Rapid Tests
    • 6.3.2.3 Others
  • 6.3.3 Market Forecast
• 6.4 Molecular Diagnostics
  • 6.4.1 Market Trends
  • 6.4.2 Major Types
    • 6.4.2.1 PCR
    • 6.4.2.2 Microassays
    • 6.4.2.3 Others
  • 6.4.3 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Clinical Pathology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Toxicology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Productivity Testing
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Animal Type

• 8.1 Livestock Animals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Companion Animals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Boehringer Ingelheim GmbH
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 IDEXX Laboratories Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Neogen Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Phoenix Central Laboratory for Veterinarians Inc. (Zoetis Inc.)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 ProtaTek International Inc (Pharmgate LLC)
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Royal GD
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Texas A&M Veterinary Medical Diagnostic Laboratory
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 VCA Inc. (Mars Incorporated)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Virbac Animal Health India Private Limited
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio